Background
==========

Since the first report of successful living donor liver transplantation (LDLT) in 1990 \[[@B1]\], LDLT has become a valuable treatment for patients with end-stage liver disease who cannot receive deceased donor livers. Particularly in children who need a small sized graft, the use of liver transplantation is limited due to shortage of deceased donor organs.

Since the safety of volunteer living donors in LDLT has always been considered paramount, evaluation of potential candidates plays a crucial role to confirm suitability and to identify possible contraindications. Each transplant center has its own protocol for living donor evaluation, which typically includes a comprehensive medical and psychosocial examination as well as non-invasive imaging and other studies to assess size, anatomy and function of the liver.

Both, contrast enhanced computed-tomography (CT), and magnetic resonance imaging (MRI) have been shown to be suitable diagnostic tools, and are being used concurrently in different centers throughout the world. Imaging in a living liver donor has three objectives: (1) to identify any intraparenchymal lesions or abnormalities like fatty changes; (2) to visualize the extra- and intrahepatic vascular and biliary anatomy; and (3) to determine the size of the whole liver and calculate the graft and remnant liver volumes. The main advantage of CT over MRI is based on a higher spatial resolution and manifold post-processing possibilities \[[@B2],[@B3]\].

The preoperative imaging process in LDLT is demanding and conscientious. Radiologists play a key role in filtering and providing the required information to surgeons. In addition, they may help to identify unsuitable donors and avoid unnecessary or invasive studies and procedures. The purpose of our study was thus to evaluate the significance of multidetector CT in this process, and therefore to reflect the radiologists impact on donor selection.

Materials and methods
=====================

This retrospective study was approved by the ethics committee of Hannover Medical School with a waiver of consent granted.

Candidate donors and recipients
-------------------------------

Between May 1999 and October 2010 170 candidate donors (92 female, 78 male, mean age 39 years, range 18-61 years) underwent biphasic CT of the liver (Table [1](#T1){ref-type="table"}). In addition, all donors had routine ultrasound examination. Further, biliary anatomy was assessed intraoperatively. The recipients were 143 patients (53 female, 90 male; 99 children, 44 adults) with a mean age of 15.3 years (4 months-71 years) (Table [2](#T2){ref-type="table"}). In 121 recipients one donor was evaluated by means of CT, in 19 recipients two donors, in 1 recipient three donors, and in 2 recipients four donors, respectively. Most common underlying diseases were biliary atresia in children (n = 69), liver cirrhosis (n = 19), and hepatocellular carcinoma respectively hepatoblastoma (n = 22). We retrospectively reviewed the results of the CT and liver volumetry, and reasons for rejection were assessed.

###### 

Candidate donor demographic data

  **Number of potential donors**   **170**           
  -------------------------------- ----------------- ----------------------------
  Donor age (years)                18-61 (mean 39)   
  Donor sex (male / female)        78 / 92           
  Performed LDLT                   89                *Mean graft volume \[ml\]*
   Left lateral                    57                277 (SD 63)
   Full left lobe                  1                 414
   Right lobe                      31                1134 (SD 317)

LDLT = living donor liver transplantation; SD = standard deviation.

###### 

Recipient demographic data

  **Number of potential recipients**   **143**
  ------------------------------------ ---------------------------------------
  Patient age                          4 months - 71 years (mean 15.3 years)
  Patient sex (male / female)          90 / 53
  Underlying disease                    
   Biliary atresia                     69
   Liver cirrhosis                     19
   Tumour (HCC, Hepatoblastoma)        22
   PSC, PBC                            7
   α1-Antitrypsin deficiency           6
   Alagille syndrome                   4
   Acute liver failure                 2
   Other                               14

Image acquisition
-----------------

Until October 2005 CT was performed using a 4-channel multi-detector row CT (Somatom Plus 4A, Siemens, Erlangen, Germany). To keep radiation dose levels as low as possible, a native CT scan was not acquired. 150 ml of a nonionic iodinated contrast agent (Ultravist 300®, Bayer Schering Pharma, Berlin) followed by a 40 ml saline flush (NaCl 0.9%) were injected at a flow of 3-5 ml/sec. Biphasic image acquisition of the liver started 5 seconds after bolus detection in the abdominal aorta for the arterial phase. Portal-venous phase scanning followed after an interscan delay of 15 seconds. The parameters were identical for both scans: 3 mm slice collimation, a table feed of 5 mm per gantry rotation, and 2 mm reconstruction interval. Starting in October 2005 CT was performed using a 64-channel scanner (Lightspeed VCT, GE Medical Systems, USA). Multiphase scanning was performed after intravenous injection of 120 ml of a nonionic iodinated contrast medium (Imeron 400®, Nycomed GmbH, Germany) followed by a 50 ml saline flush (NaCl 0,9%) at a rate of 5 ml/sec. Arterial dominant phase images were obtained 15 seconds after bolus detection in the abdominal aorta, portal-venous scanning followed after an interscan delay of 25 seconds. Again, the parameters were identical for both scans: 1.25 mm slice collimation, a table feed of 39.37 mm per gantry rotation, and 1 mm reconstruction interval.

Image analysis and postprocessing
---------------------------------

Postprocessing was performed on a commercially available workstation (ADW 2.2-4.4, GE Healthcare, USA). In addition to multiplanar reformations, maximum intensity projections (MIP) and 3D volume rendered (VR) images were used for evaluation of the vascular anatomy and identifying relevant anatomic variants. Relevant steatosis was suspected when pronounced liver-spleen attenuation was observed or the attenuation of the liver parenchyma was less than the attenuation of the muscle, as suggested by previous studies \[[@B4],[@B5]\]. In the relevant donors, liver biopsy was performed in order to confirm the degree of steatosis. Volume calculations of liver segments were performed using dedicated software (HepaVision®: MeVis, Germany) (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}) \[[@B6],[@B7]\]. Liver volumetry and segmentation was performed by an experienced radiologist, and subsequent drawing of the resection plane in agreement with the respective transplant surgeon.

![**Total liver volume was calculated using dedicated software (HepaVision®, MeVis, Germany) by tracing around the margins of the hepatic parenchyma on selected transversal slices.** Slices in between were interpolated. Large vessels as the inferior vena cava and extrahepatic portal vein were excluded. The cross sectional area (cm^2^) within the region of interest was determined, and all individual areas were summed yielding the total liver volume (cm^3^).](1471-2342-12-21-1){#F1}

![**Calculation of graft and remnant liver volume after virtual resection using HepaVision®software (MeVis, Germany).** Visualization of the resection line on transversal slices (**a**) and in 3D including hepatic veins (**b**).](1471-2342-12-21-2){#F2}

Results
=======

After completion of the evaluation process living donor liver transplantation was realized in 89 cases, respectively 52.4% (Figure [3](#F3){ref-type="fig"}). These included transplantation of the left lateral liver (segments 2 and 3) in 57 patients, transplantation of a full left lobe (segments 1-4) in one patient, and transplantation of the right lobe (segments 5-8) in 31 patients (Table [1](#T1){ref-type="table"}). For the right liver graft the resection line ran approximately 1 cm to the right of the middle hepatic vein. In one donor, a focal nodular hyperplasia was resected simultaneously, which was incidentally detected on the CT scan (Figure [4](#F4){ref-type="fig"}). In the remaining candidates surgery was not carried out either because a graft from a deceased donor became available (n = 28), death of the recipient before transplantation (n = 9) or because the donor was rejected for LDLT (n = 35). In 9 patients the evaluation process is still in progress and LDLT is planned.

![Follow-up of candidate donors being evaluated for LDLT by means of contrast enhanced CT.](1471-2342-12-21-3){#F3}

![**Donor candidate in whom the left lateral segments where resected for LDLT.** Simultaneously, a FNH in the right lobe, incidentally detected in the CT scan, was resected.](1471-2342-12-21-4){#F4}

Based on the results of contrast enhanced CT scan and liver volumetry, 22 candidates were excluded as donors. Reasons included signs of a fatty liver (n = 9) which was later on confirmed by biopsy, vascular anatomical variants (n = 4), coincidental finding of hemangioma and focal nodular hyperplasia (n = 1) or small for size (n = 5) or large for size (n = 5) graft volume, respectively. In this context small for size was defined as GRBR (graft weight to recipient to recipient body weight ratio; synonym GRWR) \<0.8%. In the five potential donors calculated as large for size the relevant grafts were left lateral segments designated for children aged 5 months to 5 years with a calculated graft volume of 345 to 511 ml. The vascular variants encountered were as follows: right hepatic artery arising from the superior mesenteric artery, left hepatic artery arising from the celiac trunk in combination with a right hepatic artery arising from the superior mesenteric artery (Figure [5](#F5){ref-type="fig"}), and atypical venous drainage of segment 5. Candidates were further excluded in the course of the evaluation process as donors due to medical reasons, such as profound arterial hypertension and unexplained elevation of transaminases, as well as social or respectively ethical reasons (e.g. poor prognosis of the recipient).

![**Maximum Intensity Projections (a,b) and 3D volume rendered image (c) in a candidate with a left hepatic artery (LHA) arising from the celiac trunk (TC) and a right hepatic artery (RHA) arising from the superior mesenteric artery (\*).** LDLT was not carried out, as graft volume was large for size.](1471-2342-12-21-5){#F5}

Discussion
==========

To meet the need of increasing potential liver transplant recipients, alternative procedures have been developed, such as reduced-size, split and living donor liver transplantation \[[@B8]\]. LDLT has two major advantages over transplantation from a brain-dead donor: excellent graft quality and reduced ischemia-reperfusion injury \[[@B9]\].

On the other hand, donor safety is the first priority. It is important to keep in mind that LDLT should only be performed if the risk to the donor is justified by expectation of an acceptable outcome in the recipient. Overall donor morbidity is estimated to be approximately 35%, including bile leakage, wound infection and ileus \[[@B10]\]. A recent survey identified 33 living liver donor deaths, including 3 donors who succumbed after an attempted rescue with a liver transplant \[[@B11]\].

Preoperative imaging of the liver is essential in order to identify and minimize the individual risk of the potential donor. It is further determining for graft survival and in preventing vascular complications. The implementation of imaging studies of the liver, the choice of the imaging modality (CT, MRI, ultrasound, angiography, e.g.) as well as the timing of imaging (early in the evaluation process vs. in the end) varies in different transplant centers.

MRI is undoubtedly becoming more significant in the course of living donor liver evaluation, due to the development of hepatobiliary-specific contrast agents and new imaging techniques (such as chemical shift imaging, MR spectroscopy), opening up new possibilities for comprehensive imaging of the liver \[[@B12],[@B13]\]. However, availability of MR is still an issue.

The purpose of this retrospective study was therefore to review the radiologist's contribution to the process of evaluation of donors for LDLT by means of contrast enhanced CT, especially since we can look back on a large group of donors being evaluated with this technique over a significant period of time. Based on the results of the CT scan and liver volumetry in our study 22 candidates were excluded as donors, which accounts for nearly one third (31%) of the cases in which LDLT was not carried out. This relatively high number could be an argument to perform CT imaging early rather than late in the process of donor evaluation. The overall costs for complete donor evaluation have been estimated in previous studies to be in the range from 1383-2569€ \[[@B14]\], in some centers even as high as 4589€ \[[@B15]\]. Early implementation of CT imaging (estimated costs of approximately 400-600€) in the evaluation process might therefore prevent further studies in unsuitable donors and reduce costs.

Nine candidate donors were excluded because CT indicated steatosis of the liver, which was confirmed with ultrasound and liver biopsy. Fatty infiltration in hepatic grafts is known to be an important risk factor for primary graft nonfunction in deceased donor liver transplantation as well as in LDLT \[[@B16],[@B17]\]. Liver grafts with a mild degree of fatty changes can be used for liver transplantation without ill effect, but liver grafts with moderate or severe degree of fatty changes have been found to have a negative effect on post transplant graft function and patient survival \[[@B17],[@B18]\]. Marcos et al estimated that 1% of hepatic steatosis can decrease the functional graft mass by 1% \[[@B19]\]. More recently the same group published a series in which no impairment in function was found in either the living donor or the recipient using grafts containing less than 30% steatosis \[[@B20]\]. In our own institution the acceptable upper limit of fatty changes in the liver graft is 30%.

10 candidate donors were excluded because of the results of liver volumetry, depicting either small (n = 5) or large for size (n = 5) graft volume. Preoperative assessment of total, graft and remnant liver volume is of utmost importance, since inadequate liver mass can influence patient and graft survival. There are several formulas for calculating total liver volume depending on the body weight, body surface and gender \[[@B21],[@B22]\]. Results do not always correlate and liver volume is often overestimated \[[@B23]\]. Depending on the individual method used, it is considered acceptable when the ratio between graft weight and recipient body weight or between graft volume and the estimated standard liver volume of the recipient are at least 0,8% and 40%, respectively \[[@B24]\].

In case of left lateral donation remnant liver volume is usually safe for the donor, whereas graft size might be too large in small children. In our study this led to the exclusion of five donors. Especially in case of right liver donation remnant liver volume might be too small (risking acute liver failure of the donor), whereas graft size might as well be too small resulting in a "small-for-size-syndrome" in the recipient, characterized by hepatocyte ballooning, steatosis, centrilobular necrosis and parenchymal cholestasis \[[@B25]\]. This led to the exclusion of three donors who were evaluated for donation of the right lobe.

CT is further important in assessment of vascular hepatic anatomy. Certain anomalies may require modification of the surgical procedure, while others might be a contraindication for surgery \[[@B26]\]. Other vascular variants may even be advantageous, e.g. a displaced right artery arising from the superior mesenteric artery in case of right donation. Due to the greater variability of the right hepatic vascular anatomy right hepatectomy can be one of the most challenging surgical procedures. In addition to the arterial supply of the graft and the remnant liver attention has to be paid to the venous drainage in order to prevent venous congestion. In our study 4 candidate donors were excluded from LDLT because of various vascular anatomic variants. Even though our reported vascular variants do not present absolute contraindications, in these specific cases LDLT would have been involved with an increased surgical complexity and an increased risk of graft failure respectively complications in the donor as well as in the recipient. It is important that anatomic vascular variants are assessed in context with the planned resection, and the decision whether a specific donor is suited for a specific recipient is in the end up to the responsible transplant surgeon.

Conclusions
===========

The use of imaging studies in the process of liver donor evaluation, specifically the choice of the imaging modality (CT, MRI, ultrasound, or angiography) as well as the timing of imaging (early in the evaluation process vs. in the end) has significant implications for the subsequent evaluation process. In our long-term experience, CT based imaging of the liver in combination with dedicated software plays a key role in the process of evaluation of candidates for LDLT. In this series almost 1/3 of donor candidates were rejected because of CT findings. CT can help to reduce the risk for donor and recipient by exclusion of unsuitable donor livers. If performed early during the evaluation process it can also prevent unnecessary studies, further reducing the risks and costs.
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